Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

This study has been completed.

Study NCT00005762 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: May 25, 2000 Last Updated: February 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	May 2004 (Final data collection date for primary outcome measure)

Publications: